|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61P 1/08 | (2006.01) |
| (11) | Number of the document | 2796171 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14173186.9 |
| Date of filing the European patent application | 2011-03-10 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-31 |
| (46) | Date of publication of the claims translation | 2018-05-10 |
| (30) | Number | Date | Country code |
| 201004020 | 2010-03-11 | GB |
| (72) |
Gilbert, Julian Clive, GB
Gristwood, Robert William, GB
Cooper, Nicola, GB
Fox, Gabriel, GB
|
| (73) |
Acacia Pharma Limited,
Harston Mill, Harston Cambridgeshire CB22 7GG,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Amisulprido panaudojimas opiatų sukelto pykinimo ir vėmimo gydymui |
| Use of amisulpride for treating opiated-induced nausea and vomiting |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 15 | 289.00 EUR |
| 2026-03-10 |